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The SWI/SNF chromatin-remodeling complex functions as a transcriptional regulator and plays a significant role in cell proliferation,
differentiation and embryonic development. SRG3, a homologue of human BAF155, is a core component of the mouse SWI/SNF chromatin
remodeling complex. Mutant mice deficient in Srg3 expression are peri-implantation lethal. To investigate the role of SRG3 in the post-implantation
stage, we generated SRG3 transgene-rescued (Srg3−/−Tg+) embryos by inducing exogenous gene expression. These Srg3−/−Tg+ embryos over-
came early embryonic lethality and extended the life span until mid-gestation. However, the embryos displayed significant defects in blood vessel
formation and fetal circulation within the yolk sac around embryonic day 10.5, which led to developmental retardation and death. We found that
SRG3 expression was absent in the visceral endoderm of Srg3−/−Tg+ yolk sacs, while SRG3 was normally expressed in wild-type embryos. In
addition, expression of angiogenesis-related genes, including Angiopoietin1, Tie2, EphrinB2, Ihh andNotch1, was markedly reduced in Srg3−/−Tg+
yolk sacs. During normal angiogenesis, maturation of the visceral endoderm development is observed in the yolk sac. However, in Srg3−/−Tg+
yolk sacs, the visceral endoderm did not develop normally. Our results indicate that SRG3 is required for angiogenesis and visceral endoderm
development in the yolk sac.
© 2007 Elsevier Inc. All rights reserved.Keywords: SRG3; SWI/SNF complex; Transgene-rescue; Angiogenesis; Yolk sac; Blood vessel; Visceral endodermIntroduction
The SWI/SNF chromatin-remodeling complex is involved in
gene activation and repression by regulating the accessibility of
transcriptional machineries to DNA (Kingston and Narlikar,
1999). Since the complex functions as a transcriptional regu-
lator, it is presumed to have a significant role in cell proli-
feration, differentiation and embryonic development (Bultman
et al., 2000; Kim et al., 2001; Muchardt and Yaniv, 2001). The
SWI/SNF complex was originally identified in the yeast. Its
core subunits, the main components of the minimum-catalytic
complex that possess chromatin-remodeling activity, are well⁎ Corresponding author. Fax: +82 2 887 9984.
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doi:10.1016/j.ydbio.2007.12.024conserved from yeast to mammals (Imbalzano, 1998; Sudarsa-
nam and Winston, 2000). BRG1 (brama-related gene 1) or
hBRM, SRG3/BAF155 and SNF5/INI1 (intergrase interactor 1)
are the core members of the complex (Phelan et al., 1999).
SRG3 serves as a scaffold, controlling the stability of the other
major components of the complex (Sohn et al., 2007).
Previous studies have shown that SRG3 is essential for
embryonic viability. Null mutant mice for SRG3 die during the
time of embryonic implantation. Some heterozygous mutant
embryos show defects in brain development (Kim et al., 2001).
These characteristics are similar to the phenotype of embryos
lacking Brg1 (Bultman et al., 2000). Recent studies using
targeted mutation of core subunits in the mouse have extended
the understanding of the roles of the mammalian SWI/SNF
complex in vivo (Bultman et al., 2000; Guidi et al., 2001; Kim
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mutations of the core subunits were peri-implantation lethal and
failed to form the inner cell mass from blastocysts in vitro
(Bultman et al., 2000; Kim et al., 2001; Klochendler-Yeivin
et al., 2000).
To overcome the barrier of early lethality, various hypomor-
phic methods have been used, including conditional knockout
of the cre-loxP system (Klochendler-Yeivin et al., 2006) or
partial loss-of-function, such as an N-ethyl-N-nitrosourea
(ENU)-induced mutation (Bultman et al., 2005). These methods
demonstrated that the SWI/SNF complex is involved in various
events during embryonic development (Bultman et al., 2005;
Klochendler-Yeivin et al., 2006). However, the function of the
SWI/SNF complex in yolk sac development and in blood vessel
formation, which occurs in the yolk sac during embryonic
development, has not been elucidated.
Embryonic blood vessel formation has two main steps: vas-
culogenesis and angiogenesis. Embryonic vessel development
begins as angioblast formation in the yolk sac at 7.0–7.5 days
post conception (dpc) (Conway et al., 2001; Neufeld et al., 1999;
Patan, 2000). This leads to the formation of the vascular plexus,
via vasculogenesis. In vasculogenesis, vascular endothelial
growth factor (VEGF) promotes the differentiation of angio-
blasts into endothelial cells in mesoderm adjacent to visceral
endoderm. VEGF binds to two tyrosine kinase receptors, KDR
and Flt1. KDR is a mouse homolog of Flk1 and is related to
vasculogenesis and blood island formation (Shalaby et al., 1995,
1997). Flt1 is also important to blood island formation, but is not
involved in endothelial cell formation (Fong et al., 1995). Null
mutant mice of these receptors die in an early embryonic
development stage. However, mutant mice lacking VEGF in a
single allele are lethal at 9 dpc and show severe defects in
vasculogenesis. This indicates that the concentration of VEGF is
important to blood vessel formation (Ferrara et al., 1996).
Angiogenesis involves the maturation and expansion of the
primitive vascular network by remodeling and sprouting bran-
ches from pre-existing vessels. Angiopoietin1 plays a key role
in this step. This soluble ligand phosphorylates the endothelial
tyrosine kinase receptor Tie2. Mutant mice lacking these sig-
naling partners show defects in vascular remodeling at mid-
gestation (Gale and Yancopoulos, 1999; Suri et al., 1996).
Visceral endoderm plays an important role in nutrient uptake
and delivery. The visceral endoderm affects mouse development
by the production and secretion of various signaling molecules
throughout development (Bielinska et al., 1999). The yolk sac
visceral endoderm, a terminal station of visceral endoderm
differentiation, is formed as the proximal visceral endoderm
migrates onto the extra-embryonicmesoderm cell layer. Yolk sac
visceral endoderm takes charge in the process of nutrient and
waste exchange until 10 dpc (Cross et al., 1994). The most
important role of the yolk sac visceral endoderm is to enhance
the formation of blood islands and the yolk sac blood vessel
network (Bielinska et al., 1996; Boucher and Pedersen, 1996;
Palis et al., 1995). As vasculogenesis commences in the yolk sac
and embryonic circulation begins, the function of exchanging
nutrients and gases is transferred from the visceral endoderm to
the vasculature. Studies of the visceral endoderm in chicken andmouse embryos demonstrate that visceral endoderm plays an
important role in induction of blood and vessel precursors
(Belaoussoff et al., 1998; Miura and Wilt, 1969).
We investigated the role of a SWI/SNF core component,
SRG3, during vascular development and visceral endoderm
maturation in the yolk sac. We focused our study of vascular
development on the yolk sac because it is the organ in which the
first blood vessels form and is the final destination of visceral
endoderm development. We have generated a SRG3 transgene-
rescued (Srg3−/−Tg+) mouse by inducing an exogenous trans-
gene into a null mutant embryo. We examined the role of SRG3
in vascular development and visceral endoderm maturation
during yolk sac development. In this study, we found that SRG3
is absent in the Srg3−/−Tg+ yolk sac visceral endoderm, while
SRG3 is present in the wild-type yolk sac. Our data reveal for the
first time that SRG3 is required for maturation of the primitive
endothelial plexus to rebuild into a functional vascular system.
However, SRG3 is not required for the process of vasculogen-
esis. In addition, our results suggest that SRG3 also plays an
essential role in development of the yolk sac visceral endoderm.
Materials and methods
Generation of SRG3 transgene-rescued (Srg3−/−Tg+) embryos
Generation of SRG3 transgenic mice was described previously (Lee et al.,
2007). SRG3 transgene-rescued (Srg3−/−Tg+) embryos were generated using
the following steps. First, double transgenic (Srg3+/−Tg+) mice were produced
by crossing SRG3 transgenic mice (Tg+) with SRG3 heterozygous mutant mice
(Srg3+/−). Then, these Srg3+/−Tg+ mice were intercrossed to generate SRG3
transgene-rescued (Srg3−/−Tg+) embryos. All experiments were carried out in a
specific pathogen-free facility in compliance with animal policies of Seoul
National University.
Genotyping of mouse embryos
Offspring were genotyped using the five-primer PCR method for selecting
double transgenic (Srg3+/−Tg+) mice, using genomic DNA extracted frommice
tails. For embryos of mid-gestational stage, genomic DNAwas prepared from a
small piece of yolk sac. The following transgene-specific primers were used: P1,
5′-GACTAGACCAAACATCTACCTC-3′; and P2, 5′-GTCAACTGAGCG
ACT TGG ATC-3′. For screening of the SRG3 allele, a common 5′ primer was
used (P3, 5′-ACAACGAAATCTGTGGAG TAGC-3′) in combination with a
SRG3-specific 3′ primer (P4, 5′-GGG ATG GGT TCT GAA GAT CA-3′) and a
Neo-specific 3′ primer (P5, 5′-CTA AAG CGC ATG CTC CAG AC-3′).
Blastocyst outgrowth analyses
Double transgenic (Srg3+/−Tg+) mice, possessing an SRG3 mutant allele
and transgene constructs, were intercrossed. At 3.5 dpc, blastocysts were flushed
from the uterine tract. Blastocysts were placed on a cell layer of mouse
embryonic fibroblasts in embryonic stem cell medium (DMEM, 15% FBS) in a
4-well dish (Nunc, Denmark). Blastocysts were cultured at 37°C in a humid
incubator infused with 5% CO2. The fibroblast cells were treated with Mito-
mycin C (10 μg/ml for 2.5 h, M4287, Sigma-Aldrich, MO) for proliferation
inhibition and washed for 2 h before analysis. After 5 days, explants were scored
for degree of outgrowth, photographed and genotyped by PCR.
RT–PCR analysis
Total RNA was extracted from the yolk sacs and fetuses of wild-type and
SRG3 transgene-rescued embryos using Trizol reagent (Invitrogen, Carlsbad,
CA). RNA extracts were treated with RNAse-free DNaseI prior to reverse
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Carlsbad, CA) according to the manufacturer's directions, the first strand was
synthesized. For real-time PCR analysis, Cybergreen (Bio-Rad, CA) was added
into the reactions. The MyiQ real-time PCR detection system (Bio-Rad, CA)
was used for PCR amplification. Each analysis was performed using three
independent PCR amplifications for each sample. Reverse transcripts were
synthesized three times from different embryos. Gapdh was used as an internal
control. PCR was performed in 50 mM Tris (pH 9.0), 16 mM (NH4)2SO4,
1.75 mM MgCl2, 1 mM dNTPs and 1 U Taq polymerase. The cycling
parameters were 94 °C for 30 s, 60 °C for 30 s and 72 °C for 30 s for 30 cycles.
Primer sequences are available upon request.
Whole-mount PECAM staining
The yolk sacs were fixed in a solution of methanol and DMSO (4:1) for 3 h
at 4 °C. Then, yolk sacs were blocked in a solution containing PBS, 2% nonfat
skim milk and 0.5% Triton X-100 (blocking solution) for 1 h at room
temperature. The yolk sacs were incubated with PECAM1 antibody (1:200 in
blocking solution, clone MEC 13.3, catalog no. 5550274; Pharmingen, CA)
overnight at 4 °C, washed three times with blocking solution for 3 h, and
incubated in anti-rat biotinylated antibody (1:500 in blocking solution)
overnight at 4 °C. Finally, yolk sacs were incubated in peroxidase-conjugated
streptavidin (ABC kit, Vector Laboratories, Burlingame, CA) for 1 h at room
temperature. Peroxidase activity was detected using the DAB method.
Histology and immunohistochemistry
All specimens (whole embryo and yolk sac) were fixed in 4% paraformalde-
hyde and 0.05% glutaraldehyde in phosphate-buffered saline (PBS) for 2 h at 4 °C,
embedded in paraffin, and serially sectioned (5 μm). Some sections were stained
with routine hematoxylin–eosin, while others were prepared for immuno-
localization of several specific molecules. Briefly, after three washes in PBS, depa-
raffinized slides were incubated in 3% H2O2 in methanol to quench endogenous
peroxidase activity. Nonspecific binding sites were blocked with serum for 1 h,
followed by overnight incubation at 4 °C with primary antibodies SRG3/BAF155
(1:100, sc-9747), BRG1 (1:80, sc-8749), VEGF (1:50, sc-507) or ANG1 (1:50, sc-
6319), each purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Slides were rinsed with PBS and incubated for 30 min at room temperature
in biotinylated antibody (1:200 in PBS, 1.5% serum). Following incubation with
the antibody, slides were incubated for 1 h in preoxidase-conjugated streptavidin
(ABC kit; Vector Laboratories, Burlingame, CA). Peroxidase activity was
detected using the DAB method. Counterstaining was performed using methyl
green (Sigma-Aldrich, MO). For negative controls, the primary antibody was
omitted from the procedure.
Transmission electron microscopy
The yolk sacs of wild-type and transgene-rescued embryos were collected at
9.5 and 10.5 dpc, and fixed in cold fixative of 2.5% glutaraldehyde in 0.1 M
phosphate buffer, pH 7.4. After overnight fixation, the yolk sacs were postfixed
in 1% OsO4, and dehydrated in graded alcohol. Decreasing concentrations of
propylene oxide and increasing EmBed-812 (Electron Microscopy Services,
Fort Washington, PA) were employed. After pure fresh resin embedding and
polymerization, 1-μm-thick sections were initially cut and stained with
Richardson's blue. Once the yolk sac visceral endoderm layer was observed
in the same section, ultra-thin sections, 60–80 nm in thickness, were made,
stained with uranyl acetate and Reynold's lead citrate, and observed with trans-
mission electron microscopy (TEM) at 80 kV using a Hitachi H7600 trans-
mission electron microscope (Hitachi, Japan).
Results
SRG3 is essential for embryonic viability
To examine the role of SRG3 during mouse embryonic
development, we designed a transgene rescue system. SRG3transgenic mice were generated using a DNA construct expres-
sing SRG3 cDNA, driven by the cytomegalovirus (CMV)
enhancer/chicken β-actin promoter (Fig. 1A). SRG3 transgenic
mice were fertile and showed a normal phenotype, except for
higher levels of SRG3 expression in the region of heart (Fig.
1B). Transgenic mice were crossed with SRG3 heterozygous
mutant (Srg3+/−) mice to obtain the SRG3 double transgenic
(Srg3+/−Tg+) mice, which carried both the transgenic construct
and SRG3 knockout allele. The Srg3+/−Tg+ mice were inter-
crossed to produce SRG3 transgene-rescued (Srg3−/−Tg+) mice.
In vitro implantation analysis revealed that Srg3−/−Tg+
blastocysts form both an inner cell mass and trophoblast.
Blastocysts at 3.5 dpc were cultured on the feeder layer of
Mitomycin C-treated mouse embryonic fibroblasts. Wild-type
(Srg3+/+), transgenic (Srg3+/+Tg+) and SRG3 heterozygous
knockout mice with (Srg3+/−Tg+) or without (Srg3+/−) the
SRG3 transgene hatched normally and produced both an inner
cell mass and trophoblast giant cells (Fig. 1C). All blastocysts
from SRG3 homozygous knockout mice lacking the SRG3
transgene (Srg3−/−) failed to induce in vitro implantation (Fig.
1C). However, The SRG3 homozygous knockout blastocysts
expressing the transgene (Srg3−/−Tg+) showed normal
implantation and inner cell mass formation (Fig. 1C). Thus,
transgene-rescued (Srg3−/−Tg+) mice developed normally
until the formation of blastocyst and the peri-implantation stage.
Transgene-rescued (Srg3−/−Tg+) mouse embryos developed
normally up to 8.5 dpc, after which time development became
severely retarded, with embryonic developmental defects more
severe. However, a large number of embryos survived up to
10.5 dpc, although they did not develop normally. These survi-
ving Srg3−/−Tg+ embryos generally appeared grossly abnormal
by 10.5 dpc and died by 11.5 dpc. Intriguingly, at 10.5 dpc,
neither blood vessels nor the circulation of fetal blood cells were
observed the yolk sacs of Srg3−/−Tg+ embryos (Fig. 2B).
Many other developmental defects were evident in Srg3−/−Tg+
embryos. These embryos were smaller, stickier and showed
developmental retardation, compared with littermate controls
(Fig. 2D). A heartbeat was observed in Srg3−/−Tg+ embryos,
but its pulse rate was slow and weak (data not shown). Inco-
ming and outgoing embryonic blood cells were not identified
in the heart. Additionally, limb bud formation did not occur
(Fig. 2D). Development of the head did not occur normally in
Srg3−/−Tg+ embryos, as the neural fold did not close (Figs.
2F, H), as it did in wild-type embryos (Figs. 2E, G).
Expression of Srg3 in the Srg3−/−Tg+ conceptuses was sig-
nificantly lower than in the wild-type embryos (Fig. 2I). In-
terestingly, Brg1 transcription levels were also significantly
down-regulated in Srg3−/−Tg+ embryos (Fig. 2I). The reduced
levels of Srg3 and Brg1 and the unclosed neural fold in the head
of Srg3−/−Tg+ embryos recapitulate the defects in brain
development of SRG3 and BRG1 heterozygous mutant mouse
embryos (Bultman et al., 2000; Kim et al., 2001).
Vascular abnormalities in the Srg3−/−Tg+ yolk sac
The yolk sacs of Srg3−/−Tg+ mouse embryos showed
vascular development defects. By 10.5 dpc, wild-type yolk
Fig. 1. Preparation of SRG3 transgenic mice. (A) Transgenic construct and schematic diagram of the Srg3 locus and targeted allele. The blue columns represent Srg3
exons (III–V) and the white column depicts a neomycin resistance cassette (Neor). Arrows P1–P5 indicates the position and orientation of oligomers for genotyping in
(C). pA, polyadenylation sequence. Oligomer P3 is common to both wild-type and mutant alleles. (B) Western blot analysis of SRG3 expression in adult organs of both
transgenic mice and littermate controls (8 weeks old). Glucocorticoid receptor (GR) and actin were used as internal controls. (C) Phase contrast view of E3.5
blastocysts from Srg3+/−Tg+ mice intercrosses. Genotyping results are shown on the bottom right side of each panel. The transgenic fragment (800 bp) was amplified
by the P1–P2 primer pair, while the wild-type fragment (450 bp) was amplified by the P3–P4 primer pair and the mutant fragment (250 bp) was amplified by the P3–
P5 primer pair. Arrow, inner cell mass; arrowhead, a single layer of trophoblast giant cells.
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filled with blood (Figs. 2A and 3A), while the vasculature within
Srg3−/−Tg+ yolk sacs was poorly developed (Figs. 2B and 3B).
In the Srg3−/−Tg+ embryos, mature vasculature did not develop,
although blood island formation was observed (Fig. 3B). These
defects in vascular development led to extensive leakage of fetal
blood cells or hematopoietic cells within embryos (Fig. 2D).
Histological analysis indicated that mature blood vessels
were absent in the Srg3−/−Tg+ yolk sacs (Fig. 3B). On the
other hand, blood vessels in wild-type yolk sacs were well-
formed and contained hematopoietic cells (Fig. 3A). Immuno-histochemical analyses showed that SRG3 expression was
dramatically reduced in Srg3−/−Tg+ yolk sacs compared to
wild-type (Figs. 3C, D). Note that SRG3 expression in the
region of yolk sac visceral endoderm was totally absent (Fig.
3D, asterisk). BRG1 was detected in Srg3−/−Tg+ yolk sacs at
significantly down-regulated levels (Fig. 3F). Semi-quantita-
tive RT–PCR analysis confirmed that Srg3 and Brg1 expres-
sion in Srg3−/−Tg+ yolk sacs were significantly reduced as
compared to wild-type yolk sacs (Fig. 3G). The lack of SRG3 in
Srg3−/−Tg+ yolk sacs suggests a role of SRG3 in the vascular
development of the yolk sac.
Fig. 2. Phenotype of SRG3 transgene-rescued (Srg3−/−Tg+) embryos. (A–H) Conceptuses of 10.5 dpc wild-type (A, C, E, G) and Srg3−/−Tg+ embryos (B, D, F, H).
Note the presence of large collection vessels and circulation (arrow). (E) Normal developed head region of 10.5 dpc wild-type embryo. (F) A head region of 10.5 dpc
Srg3−/−Tg+ embryo. Note that the neural fold remains unclosed (arrowhead). (G, H) Sagittal sections of 10.5 dpc wild-type and Srg3−/−Tg+ embryos stained by
hematoxylin–eosin. The arrowhead indicates the unclosed neural fold in the head region of an Srg3−/−Tg+ embryo. (I) The expression level of Srg3 and Brg1
transcripts in the conceptuses of 10 dpc wild-type and Srg3−/−Tg+ embryos. Srg3+/+ is the littermate control for the 10.5 dpc Srg3−/−Tg+ embryo. Semi-
quantitative RT–PCR and real-time PCR were performed with cDNA from each embryo. Error bars represent SD (n=3). Scale bars: 1 mm.
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During mouse embryonic development, the yolk sac is the
first place where blood vessel formation occurs. Blood vessel
formation occurs in two main steps: vasculogenesis and angio-
genesis. Vasculogenesis leads to the beginning of vessel form-
ation. In the yolk sac, the differentiation and aggregation of
angioblasts occurs, along with the formation of a primarycapillary plexus of simple endothelial cells. To observe whether
primitive networks exist in the yolk sac of Srg3−/−Tg+ em-
bryos, we examined whole-mount staining using PECAM1, an
endothelial cell marker (Fig. 4). The presence of a primary
plexus suggests that the early step of vasculogenesis com-
mences in Srg3−/−Tg+ embryos. Additionally, the formation
and aggregation of endothelial cells is not dependent on SRG3
expression.
Fig. 3. Yolk sac defects in Srg3−/−Tg+ embryos. Histological and immunohistochemical analyses were performed in 10.5 dpc wild-type and SRG3 transgene-rescued
(Srg3−/−Tg+) yolk sacs. (A, B) Hematoxylin–eosin staining of yolk sacs from 10.5 dpc wild-type and Srg3−/−Tg+ embryos. (C) Anti-SRG3/BAF155 antibody was
used to stain the nuclei of yolk sacs (asterisk) in wild-type mouse embryos. In contrast, SRG3 is not detected in the yolk sacs of the Srg3−/−Tg+ embryos (D, asterisk).
(E, F) Anti-BRG1 antibody stained the nuclei of yolk sacs (asterisk). (G) The expression level of Srg3 and Brg1 transcripts in yolk sacs of 9.5 dpc and 10.5 dpc wild-
type and 10.5 dpc Srg3−/−Tg+ embryos. Srg3+/+ is littermate control of 10.5 dpc Srg3−/−Tg+ embryo. Semi-quantitative RT–PCR and real-time PCR were
performed with cDNA from each yolk sac. Error bars represent SD (n=3). Scale bar: 50 μm.
Fig. 4. Blood vessel formation in Srg3−/−Tg+ yolk sacs. Visualization of
endothelial cells expressing PECAM1 in yolk sacs. Whole-mount immunostain-
ing of 9.5 dpc and 10.5 dpc wild-type yolk sacs (left) and Srg3−/−Tg+ yolk sacs
(right). Wild-type yolk sacs show large maturated vessels at both 9.5 dpc and
10.5 dpc (arrowheads). Srg3−/−Tg+ yolk sacs lack mature vasculature. Scale
bars: 200 μm.
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the process of vascular remodeling and refining occurs during
angiogenensis. During angiogenesis, pre-existing vessels deve-
lop into distinguishable large and small vessels. Endothelial
cells of Srg3−/−Tg+ yolk sacs were not developed into mature
blood vessel network. Rather, they remained a primitive net-
work showing a honeycomb-like structure (Figs. 4B, D), a fea-
ture of an immature vascular plexus. However, wild-type em-
bryos showed extensive organized and mature vasculature,
consisting of both large vessels and capillary beds (Figs. 4A, C).
Deficiency in blood vessel refinement in Srg3−/−Tg+ yolk sacs
suggests that vascular development in the Srg3−/−Tg+ yolk sac
is arrested before angiogenesis commences.
SRG3 regulates the expression of angiogenic genes
Numerous signaling pathways are involved in regulating
vasculature formation during embryonic development (Rossant
and Howard, 2002). To examine how SRG3 plays a role in
blood vessel development in yolk sacs, we analyzed the expres-
sion of vasculature-related genes using semi-quantitative RT–
PCR (Fig. 5).
Fig. 5. RT–PCR analysis of angiogenic genes in SRG3 transgene-rescued (Srg3−/−Tg+) yolk sacs. cDNAwas synthesized from RNA extracted from the individual
yolk sacs of 10.5 dpc Srg3−/−Tg+ and 10.5 dpc Srg3+/+ littermates, along with 9.5 dpc Srg3+/+ embryos. Semi-quantitative RT–PCR and real-time PCR were
performed with synthesized cDNA. Vegfa and Ang1 and their related genes are shown on the left. Expression of Srg3 is shown on the bottom right side. Ang1,
EphrinB2, Ihh, and their receptors and Notch1 and Hey1 were down-regulated in Srg3−/−Tg+ yolk sacs. Gapdh was used to normalize each sample. Error bars
represent SD (n=3).
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factor genes, vascular endothelial growth factor (VEGF) and
Angiopietin1 (ANG1). While VEGF plays an essential role in
the formation of new vessels, ANG1 is involved in the matu-
ration and remodeling of the primary plexus. The expression of
Vegf did not notably change in Srg3−/−Tg+ yolk sacs, while
Ang1 expression was considerably down-regulated (Fig. 5, left).
Hypoxia is also known to affect the regulation of these
factors by inducing hypoxia-inducible factor 1α (Hif1α) (Iyer
et al., 1998). Thus, we inspected whether the hypoxia condition
is changed in Srg3−/−Tg+ embryos by checking the Hif1α ex-
pression level. Consequently, there was no significant change in
Hif1α expression compared to the wild-type (data not shown),
indicating that hypoxia condition did not affect Srg3−/−Tg+
embryos.
Vascular development is regulated through interactions
between soluble vasculature-related factors and their receptors.
Therefore, we examined the expression of the VEGF receptors
KDR and Flt1. KDR is a mouse homologue of Flk1, while Flt1
is the earliest marker of the developing endothelial lineage. We
also examined the expression of the ANG1 receptor Tie2, which
is expressed in endothelial cells. The expression of Kdr and
Flt1 in the Srg3−/−Tg+ yolk sacs was not significantly different
from controls. However, the expression of Tie2 was down-
regulated in Srg3−/−Tg+ yolk sacs (Fig. 5, left). These dataimplicate a role of SRG3 in angiogenesis, but not vasculogen-
esis, during blood vessel development in the yolk sacs.
Next, we examined other vasculature-related signaling
pathways essential for vascular remodeling in the yolk sac,
including Hedgehog, Eph/ephrin and Notch signaling. Defi-
ciency in the members of these pathways leads to severe defects
in blood vessel remodeling in yolk sacs during mouse em-
bryonic development (Adams, 2002; Byrd et al., 2002; Krebs
et al., 2000). Such deficiencies are morphologically very similar
to Srg3−/−Tg+ embryos. In Srg3−/−Tg+ yolk sacs, transcript
levels of both Ihh (Indian hedgehog) and its receptor Ptch1/2
were down-regulated (Fig. 5, right). Notch1 and its target
molecule, Hey1, were reduced in Srg3−/−Tg+ yolk sacs (Fig. 5,
right). Moreover, both ephrinB2 and EphB4, a key ligand and
receptor of Eph/ephrin pathway, were also down-regulated in
the Srg3−/−Tg+ yolk sac (Fig. 5, right).
Another important molecule that plays an essential role in
yolk sac vascular development is Furin. Deficiency of the Furin
gene (fur) leads to early embryo lethality and shows dis-
organized vasculature in the yolk sac (Roebroek et al., 1998).
Semi-quantitative RT–PCR analysis showed that fur was signi-
ficantly down-regulated in the Srg3−/−Tg+ yolk sac compared
with wild-type yolk sacs (Fig. 5, right). Our results indicate that
the expression of most angiogenesis-related genes, but not vas-
culature-related genes, are dependent on the expression of
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for angiogenesis during blood vessel development in yolk sacs.
Immunohistochemical analyses of yolk sacs in 10.5 dpc
wild-type and Srg3−/−Tg+ embryos were performed using anti-
ANG1 and anti-VEGF antibodies. We confirmed that ANG1
protein levels were down-regulated in Srg3−/−Tg+ embryos. In
Srg3−/−Tg+ yolk sacs, the expression level of ANG1
significantly decreased, while the VEGF expression did not
change (Figs. 6B, D).
Aberrant visceral endoderm development in the Srg3−/−Tg+
yolk sac
The visceral endoderm has essential roles during mouse
embryonic development, such as nutrient uptake, nutrient
transport and guiding the early development of the embryo.
The yolk sac is the final destination in visceral endoderm
development; the yolk sac visceral endoderm affects embryonic
development until birth (Bielinska et al., 1999; Cross et al.,
1994). A number of signaling molecules released from the
visceral endoderm of the yolk sac regulate the formation of
blood islands and the differentiation into hematopoietic and
endothelial cells. Electron microscopy analysis showed that
distorted microvilli and excessive amount of vesicles and
vacuoles were present in the visceral endoderm of Srg3−/−Tg+
yolk sacs (Figs. 7A–C). The absence of SRG3 expression in the
yolk sac visceral endoderm region of Srg3−/−Tg+ embryos
suggests that SRG3 plays a role in yolk sac visceral endoderm
development.
GATA-4 and GATA-6, two zinc finger transcription factors,
induce various genes required for early embryonic develop-
ment. Failure of induction of these genes leads to severe defects
in visceral endoderm formation (Bielinska and Wilson, 1997;
Soudais et al., 1995). In the Srg3−/−Tg+ yolk sac, the expres-Fig. 6. VEGF and Angiopoietin1 (ANG1) expression in yolk sacs. Sections of y
(Srg3−/−Tg+) embryos were stained with each antibody. (A, B) VEGF expression
expression was remarkably reduced in 10.5 dpc Srg3−/−Tg+ yolk sacs. (E, F) ANG1sion level of GATA-4 was reduced by a small amount, while
there was no significant change in GATA-6 expression (Fig.
7D). Interestingly, reduction in the expression of Furin, an
important molecule for visceral endoderm development (Bie-
linska et al., 1999), indicates that SRG3 affects the maturation
of yolk sac visceral endoderm development (Fig. 7D).
Discussion
Since SRG3 null mutant mice die at the implantation stage,
the role of SRG3 during development has not been deter-
mined. In this study, we investigated the role of SRG3 using a
transgene-rescue strategy. The peri-implantation lethality of
the SRG3 null mutant (Srg3−/−) embryos was overcome by
exogenous expression of the SRG3 transgene driven by the
chicken β-actin promoter. The transgene recovered the loss of
SRG3 expression partially. Therefore, the transgene-rescued
(Srg3−/−Tg+) embryo showed defects in both extra-em-
bryonic tissues including the yolk sac and retardation in the
developing embryo. The arrest of growth and development in
the embryo suggests that SRG3 is essential for developmental
events.
We determined that the yolk sac is a region where SRG3 is
normally expressed. SRG3 is expressed in the yolk sac visceral
endoderm throughout development. This region is severely
affected by the absence of SRG3. The Srg3−/−Tg+ embryo
showed defects in the visceral endoderm development of the
yolk sac, indicating that SRG3 is required for formation and
maturation of the yolk sac visceral endoderm. A major defect in
Srg3−/−Tg+ yolk sacs is an arrest in vascular development,
which results in a failure of blood to circulate. The yolk sac is
the first organ in which hematopoiesis and angiogenesis occur
during embryonic development. Severe defects in the yolk sacs
led to developmental failure in Srg3−/−Tg+ embryos.olk sacs from 9.5 dpc and 10.5 dpc wild-type and SRG3 transgene-rescued
did not significantly change in 10.5 dpc Srg3−/−Tg+ yolk sacs. (C, D) ANG1
expression was also reduced in 9.5 dpc Srg3−/−Tg+ yolk sacs. Scale bar: 50 μm.
Fig. 7. Impairment in visceral endoderm development of the Srg3−/−Tg+ yolk sac. (A–C) Electron microscopy of the visceral endoderm region in 9.5 dpc (A) and
10.5 dpc wild-type yolk sacs (B), and 10.5 dpc Srg3−/−Tg+ yolk sacs (C). Note the normal arrangement of microvilli and mature visceral endoderm cells in both
9.5 dpc and 10.5 dpc wild-type yolk sacs (A, B). However, distortion of microvilli and numerous vesicles and vacuoles were present in the visceral endoderm cells
of Srg3−/−Tg+ yolk sacs (C). (D) The expression level of visceral endoderm development-related genes. Semi-quantitative RT–PCR and real-time PCR were
performed with cDNA from each yolk sac of 9.5 dpc and 10.5 dpc wild-type and 10.5 dpc Srg3−/−Tg+ embryos. Srg3+/+ served as a littermate control for 10.5 dpc
Srg3−/−Tg+ embryos. In the yolk sac of Srg3−/−Tg+ embryos, Gata4 was slightly down-regulated, but Gata6 was not changed significantly. Error bars represent
SD (n=3). *Pb0.05 (Student's t test). Scale bar: 2 μm.
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Several studies have demonstrated the importance of the
SWI/SNF chromatin remodeling complex during mouse em-
bryonic development. However, the expression patterns of its
components, including SRG3 and BRG1, during development
have not been determined. Although expression patterns and
transcription profiling of Srg3 and Brg1 in whole embryos have
been examined (Bultman et al., 2000; Kim et al., 2001), their
expression patterns in extra-embryonic tissues have not been
reported.
In this study, we found that SRG3 is expressed in the yolk
sac during embryonic development. The expression of SRG3 is
observed in the yolk sac at 7.5 dpc and persists after 10.5 dpc
(data not shown). In the yolk sac of Srg3−/−Tg+ embryos,
SRG3 was barely detected, while severe defects in yolk sac
development were found. Intriguingly, decreased expression of
BRG1 and its reduced transcript level was found in the same
regions. SRG3 interacts with and stabilizes major components
of the SWI/SNF complex, including BRG1, SNF5, and
BAF60a, indicating a scaffold function of SRG3 (Sohn et al.,
2007). It is interesting to note that the BRG1 transcript was also
down-regulated in the Srg3−/−Tg+ yolk sac, suggesting that
SRG3 may regulate the SWI/SNF complex activity at a trans-
criptional as well as a protein level.Regulation of angiogenesis by SRG3
Normal differentiation of endothelial cells occurred in the
yolk sac of Srg3−/−Tg+ embryo. However, the remodeling of
the primary vascular plexus was abnormal. This feature of en-
dothelial cell development in Srg3−/−Tg+ embryos is similar to
the phenotype of mouse embryos carrying a mutation for Angio-
poeitin1 (ANG1) and its receptor, Tie1/2 (Sato et al., 1995).
Thus, in the yolk sacs of Srg3−/−Tg+ embryos, vasculogenesis
occurs, while angiogenesis is arrested at an early stage.
Various signaling pathways involving soluble growth factors
and their receptors direct blood vessel formation in embryonic
development. In the Srg3−/−Tg+ yolk sac, vasculogenesis-
related genes such as VEGF, KDR, and Flt1 were expressed
normally. Furthermore, normal expression of KDR indicates that
endothelial cells are developed and well-aggregated (Millauer
et al., 1993). Expression of these receptors is enhanced by
VEGF. Their expression was detected in the yolk sac, where
SRG3 expression is significantly reduced. Therefore, SRG3
does not affect the expression of VEGF and its receptors or
endothelial cell differentiation in the yolk sac.
Several signaling molecules essential for angiogenesis have
been reported, such as Ihh, Notch and Eph/ephrin signaling
pathway.We tested the expression of these genes in Srg3−/−Tg+
yolk sacs. Consistent defects in the expression of these genes
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endoderm after gastrulation; its expression is maintained until
after 12.5 dpc (Byrd et al., 2002). The loss of Ihh (Indian
hedgehog) results in severe vascular defects during blood vessel
maturation (Byrd et al., 2002). In the yolk sac, Ihh acts through
binding to its receptor patched (Ptch). We determined that Ihh
and its receptors, Ptch1/2, were down-regulated in the yolk sacs
of Srg3−/−Tg+ embryos.
The Notch signaling pathway has been shown to be a
determining factor of cell fate specification (Kojika and Griffin,
2001). In vascular development, Notch signaling is hypothe-
sized to influence the commitment of the angioblast to an artery
versus vein fate (Rossant and Howard, 2002). Mice with muta-
tions in the Notch signaling pathway show vascular defects
similar to those observed in Srg3−/−Tg+ yolk sacs (Krebs et al.,
2000). As expected, Hey1, a gene downstream of Notch1, was
also down-regulated in Srg3−/−Tg+ yolk sacs.
The Eph/ephrin pathway is also required for blood vessel
maturation during embryonic development (Adams, 2002).
Both ephrinB2 ligand and EphB4 receptor are normally ex-
pressed in yolk sac blood vessels. While ephrinB2 is expressed
in the endothelial cells that differentiate into arteries, EphB4 is
expressed in venous endothelial cells from an early stage of
vascular development (Wang et al., 1998). However, when
ephrinB2 or EphB4 are mutated, a normal primary plexus
forms, but defects in vascular remodeling in the yolk sacs are
evident (Gerety et al., 1999; Wang et al., 1998). This is mor-
phologically similar to the Srg3−/−Tg+ embryos. Consistent
with these results, we found that EphrinB2 and EphB4 were
also down-regulated in Srg3−/−Tg+ yolk sacs.
From 7.5 dpc, Furin is produced in the extra-embryonic
endoderm, which becomes the visceral endoderm. Mice lacking
Furin die at 10.5–11.5 dpc and show developmentally severe
defects (Roebroek et al., 1998). The yolk sacs of Furin knockout
mouse embryos fail to develop large blood vessels. However,
endothelial precursors expressing KDR, an endothelial cell
marker, are present (Roebroek et al., 1998). The expression level
of Furin was significantly down-regulated in the Srg3−/−Tg+
yolk sac.
SRG3 is required for yolk sac visceral endoderm development
Visceral endoderm originates from the hypoblast at the
blastocyst stage (Gardner, 1983; Hogan et al., 1994). In the early
stage, the visceral endoderm plays important roles in the absorp-
tion and digestion of maternal nutrient and in the exchange of
gases between mother and embryo (Bielinska et al., 1999).
Therefore, the visceral endoderm contains a number of pha-
gocytic and pinocytic vesicles. Visceral endoderm synthesizes
and releases many molecules related to nutrient transport and
embryonic development, including the differentiation and
formation of blood islands and blood vessels (Boucher and
Pedersen, 1996; Cross et al., 1994; Freeman, 1990). Hence,
severe defects in visceral endoderm development affect blood
cell and blood vessel formation during vertebrate development
(Winnier et al., 1995). As vasculogenesis commences in the yolk
sac and embryonic circulation begins, the function of exchan-ging nutrients and gases is transferred from the visceral
endoderm to the vasculature (Bielinska et al., 1999). In addition,
phagocytic and pinocytic vesicles disappear after fetal blood cell
begins to flow. Srg3−/−Tg+ yolk sac contained several vesicles
and distorted microvilli in the yolk sac visceral endoderm,
indicating that the visceral endoderm of the Srg3−/−Tg+ yolk
sac did not develop normally.
GATA-4 and GATA-6 are important factors for visceral
endoderm development. There are zinc finger transcription
factors that induce the expression of numerous genes in cardio-
myocytes and endoderm derivatives, including the visceral
endoderm (Bossard and Zaret, 1998; Heikinheimo et al., 1997).
The examination of embryoid bodies differentiated from em-
bryonic stem cell shows that deficiency of GATA-4 and GATA-6
leads to defects in visceral endoderm formation and reduction of
many visceral endoderm markers (Bielinska and Wilson, 1997;
Soudais et al., 1995). However, mice lacking GATA-6 die 2–
4 days earlier than GATA-4 knockout mice, indicating that
GATA-6 is an early factor required for proper differentiation of
the visceral endoderm (Bielinska et al., 1999; Koutsourakis et al.,
1999; Molkentin et al., 1997). In the yolk sacs of Srg3−/−Tg+
embryos, GATA-4 expression was slightly reduced, but GATA-6
expression remained normal. GATA-4 heterozygous mutant em-
bryos shows normal developmental features (Molkentin et al.,
1997), suggesting that a slight reduction of GATA-4 in the
Srg3−/−Tg+ yolk sac likely do not significantly contribute to
the defects in yolk sac visceral endoderm development.
Furin is another important factor in visceral endoderm deve-
lopment. Furin activates precursors of signaling molecules
related to development, such as insulin-like growth factor-I and
members of the transforming growth factor β (TGF-β) family
(Dubois et al., 1995; Duguay et al., 1997). Furin is made in the
visceral endoderm from 7.5 dpc, which is later in development
than GATA-4/6 expression (Roebroek et al., 1998). Therefore,
reduced expression of Furin in the Srg3−/−Tg+ yolk sac sug-
gests that SRG3 is involved in the late stage of yolk sac visceral
endoderm development by regulating Furin expression. How-
ever, it is unclear whether an insufficient vasculature system
leads to abnormal visceral endoderm development, or vice versa.
Down-regulation of angiogenesis-related genes in the yolk
sacs of Srg3−/−Tg+ embryos accounts for severe defects ob-
served in yolk sac vasculature maturation. In Srg3−/−Tg+ yolk
sacs, several genes involved in angiogenesis and visceral endo-
derm development were down-regulated. In addition, reduced
Brg1 expression in Srg3−/−Tg+ embryos supports the hypoth-
esis that SRG3 is a key regulator of activity of SWI/SNF com-
plex. It is unclear whether these genes are regulated directly by
the SWI/SNF complex or indirectly through the control of co-
modulators of their upstream targets. Nevertheless, it is clear
that the SWI/SNF chromatin remodeling complex plays a cri-
tical role in the regulation of angiogenesis-related genes during
embryonic development.
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